radium and lutetium
radium has been researched along with lutetium in 9 studies
Research
Studies (9)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors
Authors | Studies |
---|---|
Atkinson, MJ; Erfle, V; Gössner, W; Linzner, U; Luz, A; Müller, K; Müller, WA; Murray, AB; Schmidt, J; Strauss, PG | 1 |
Luz, A; Müller, WA; Schäffer, EH | 1 |
Gössner, W; Luz, A; Müller, WA; Schäffer, EH | 1 |
Guerra Liberal, FD; Tavares, AA; Tavares, JM | 1 |
Amato, E; Baldari, S; Italiano, A; Leotta, S | 1 |
Ahmadzadehfar, H; Essler, M; Gaertner, F; Schlenkhoff, CD; Schmidt, M | 1 |
Ferretti, A; Gross, MD; Rubello, D; Viglianti, BL; Wale, DJ; Wong, KK | 1 |
Aranda-Lara, L; Azorín-Vega, E; Ferro-Flores, G; Jiménez-Mancilla, N; Nava-Cabrera, MA; Rojas-Calderón, E | 1 |
Bundschuh, RA; Dittmann, H; Eiber, M; Essler, M; Fendler, WP; Fougère, C; Hasa, E; Kurtinecz, M; Pabst, KM; Prasad, V; Rahbar, K; Rassek, P; Sartor, O; Schmall, A; Verholen, F | 1 |
Reviews
2 review(s) available for radium and lutetium
Article | Year |
---|---|
Bone tumor induction after incorporation of short-lived radionuclides.
Topics: Animals; Bone Neoplasms; Lutetium; Mice; Neoplasms, Radiation-Induced; Radium; Thorium | 1991 |
Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma.
Topics: Bone Neoplasms; Clinical Trials as Topic; Humans; Lutetium; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Radium | 2019 |
Other Studies
7 other study(ies) available for radium and lutetium
Article | Year |
---|---|
The osteosarcomogenic efficiency of low 224radium-doses in mice compared to that of the short-lived beta-emitting rare earth 177lutetium.
Topics: Animals; Bone Neoplasms; Dose-Response Relationship, Radiation; Female; Lutetium; Mice; Neoplasms, Radiation-Induced; Radioisotopes; Radium; Sarcoma, Experimental; Thorium | 1985 |
The role of time-factor and RBE for the induction of osteosarcomas by incorporated short-lived bone-seekers.
Topics: Animals; Bone Neoplasms; Lutetium; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Osteosarcoma; Radioisotopes; Radium; Relative Biological Effectiveness; Strontium Radioisotopes; Thorium; Time Factors | 1983 |
Comparative analysis of 11 different radioisotopes for palliative treatment of bone metastases by computational methods.
Topics: Algorithms; Beta Particles; Bone Neoplasms; Computer Simulation; DNA; DNA Damage; DNA Repair; Humans; Lutetium; Monte Carlo Method; Neoplasm Metastasis; Palliative Care; Radioisotopes; Radiopharmaceuticals; Radium; Rhenium; Samarium; Strontium Radioisotopes | 2014 |
A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals.
Topics: Capillaries; Indium Radioisotopes; Iodine Radioisotopes; Isotope Labeling; Lutetium; Monte Carlo Method; Neoplasms; Nuclear Medicine; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radium | 2015 |
Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer.
Topics: Aged; Anemia; Antineoplastic Agents; Bone Marrow Diseases; Bone Neoplasms; Compassionate Use Trials; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Technetium Tc 99m Medronate | 2016 |
Assessment of the radiation absorbed dose produced by
Topics: Actinium; Antigens, Surface; Bone Neoplasms; Cell Line, Tumor; Cell Nucleus; Computer Simulation; Glutamate Carboxypeptidase II; Humans; Lutetium; Male; Models, Biological; Monte Carlo Method; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Radium; Tumor Microenvironment | 2019 |
Safety and Survival Outcomes of
Topics: Dipeptides; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium; Retrospective Studies; Treatment Outcome | 2023 |